The goal of this activity is for learners to be better able to identify approaches to anticoagulation for thromboembolic disease, gaps in current management related to thromboembolic protection, and the future of thrombosis prevention with factor XI inhibitors in the setting of atrial fibrillation, secondary stroke prevention, acute coronary syndrome, and venous thromboembolism.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001646
- Start Date: 2024-09-24 05:00:00
- End Date: 2024-09-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 40939.0 - Is Kind Support: False Source: Johnson & Johnson - Amount: 40939.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine
Subscribe
Login
0 Comments
Oldest